In CSF, amyloid-beta1-42 (Aβ42), total tau (t-tau) and phosphorylated tau (p-tau) and their relative ratios have been linked to different aspects of AD pathology [13–18]. The gene discussed is MAPT; the disease is Alzheimer disease.